Haemonetics Corp (HAE)
85.55
+0.12
(+0.14%)
USD |
NYSE |
Nov 22, 16:00
83.01
-2.54
(-2.97%)
Pre-Market: 20:00
Haemonetics Cash from Operations (Quarterly): 48.82M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 48.82M |
| June 30, 2024 | -27.42M |
| March 31, 2024 | 64.08M |
| December 31, 2023 | -0.54M |
| September 30, 2023 | 99.12M |
| June 30, 2023 | 19.09M |
| March 31, 2023 | 79.61M |
| December 31, 2022 | 64.42M |
| September 30, 2022 | 87.04M |
| June 30, 2022 | 41.99M |
| March 31, 2022 | 68.05M |
| December 31, 2021 | 62.43M |
| September 30, 2021 | 43.46M |
| June 30, 2021 | -1.68M |
| March 31, 2021 | 1.547M |
| December 31, 2020 | 66.29M |
| September 30, 2020 | 29.16M |
| June 30, 2020 | 11.81M |
| March 31, 2020 | 46.41M |
| December 31, 2019 | 79.28M |
| September 30, 2019 | 29.90M |
| June 30, 2019 | 2.628M |
| March 31, 2019 | 20.64M |
| December 31, 2018 | 58.16M |
| September 30, 2018 | 57.36M |
| Date | Value |
|---|---|
| June 30, 2018 | 23.12M |
| March 31, 2018 | 57.63M |
| December 31, 2017 | 65.40M |
| September 30, 2017 | 58.90M |
| June 30, 2017 | 38.42M |
| March 31, 2017 | 34.58M |
| December 31, 2016 | 55.20M |
| September 30, 2016 | 39.26M |
| June 30, 2016 | 30.70M |
| March 31, 2016 | 53.25M |
| December 31, 2015 | 31.85M |
| September 30, 2015 | 27.51M |
| June 30, 2015 | 9.25M |
| March 31, 2015 | 55.30M |
| December 31, 2014 | 26.89M |
| September 30, 2014 | 31.24M |
| June 30, 2014 | 13.74M |
| March 31, 2014 | 51.47M |
| December 31, 2013 | 45.29M |
| September 30, 2013 | 29.36M |
| June 30, 2013 | 13.40M |
| March 31, 2013 | 27.54M |
| December 31, 2012 | 23.96M |
| September 30, 2012 | 33.01M |
| June 30, 2012 | 0.553M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.42M
Minimum
Jun 2024
99.12M
Maximum
Sep 2023
44.15M
Average
47.61M
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Globus Medical Inc | 203.65M |
| ResMed Inc | 325.54M |
| Baxter International Inc | 253.00M |
| Integra Lifesciences Holdings Corp | 22.48M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -23.37M |
| Cash from Financing (Quarterly) | -74.80M |
| Free Cash Flow | 20.35M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 38.02M |
| Free Cash Flow to Firm (Quarterly) | 44.68M |
| Free Cash Flow Yield | 0.46% |